I think it plays into what we're talking about here in terms of the--how we lower the costs.

I think that that's just one tool in the tool box. I would argue we need a broader set of tools.

I think it's hard when you pick up the phone and you call an agency and there's no one there on Friday to answer the phone.

They're using that as basically an energy weapon, if you will.

I just do not believe that.

We have made America a more compassionate and more just society.

I believe efforts to repeal it are ill-advised, and trying to fight last year's or last couple years' battles.

Our thoughts are with the Japanese people and with the rescuers and responders, including units from our own country.

I hope that FEMA will have made significant progress in improving our Nation's preparedness for the next catastrophe.

Let me ask just a couple of quick questions on review processes, particularly since you mentioned you might have some other ways to try to get these products that Chairman Kohl was talking about to the market quicker.

I pushed very hard for this reform, I am very pleased to see the progress that has been made.

I think in fiscal year 2009, the agency failed to meet one-third of its drug review goals and approximately 20 percent of its device review goals.

I want to ask you a series of questions about that, but since my time on this round is almost expired, I will wait for the next round.

I think it is a false choice between providing the money quickly enough and providing it in a way that guards against fraud.

And were not those $2,000 debit cards just an invitation to improper spending?

I think it is worth the money of going after it because of the message it sends that it is not going to be tolerated.

I want to say, here and now, that we are not going to give out $2,000 debit cards.

I do want to point out some bright spots in the September 2010 DHS Inspector General's report.